We are live on ! Find out more
LFSC

F/m Emerald Life Sciences Innovation ETF

2 hedge funds and large institutions have $47.3M invested in F/m Emerald Life Sciences Innovation ETF in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

97.23% more ownership

Funds ownership: 0%97.23% (+97%)

Holders
2
Holders Change
+2
Holders Change %
% of All Funds
0.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
2
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EMFAT
1
Emerald Mutual Fund Advisers Trust
Pennsylvania
$46.7M +$50.5M +1,997,035 New
HAIM
2
Hunter Associates Investment Management
Pennsylvania
$590K +$641K +25,310 New

LFSC Hedge Fund Activity: Q4 2024 in Review

2 of the 7,602 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q4 2024, worth a combined $47.3M.

Buyers outnumbered sellers: 2 funds opened new LFSC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Emerald Mutual Fund Advisers Trust, opening a new position worth an estimated $50.5M.

  • 2 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $47.3M of F/m Emerald Life Sciences Innovation ETF stock for Q4 2024.
  • 2 funds opened new F/m Emerald Life Sciences Innovation ETF positions in Q4 2024 and 0 closed out, a net change of +2 holders.
  • The largest F/m Emerald Life Sciences Innovation ETF buyer in Q4 2024 was Emerald Mutual Fund Advisers Trust, an estimated $50.5M added.

Based on aggregated 13F filings for Q4 2024.